Evaluating only Lumiata’s profile at its peak — without knowing the outcome — the model ranked Competition as the #1 likely cause. Documented cause: Regulation.
Key Events Timeline
FOUNDING
Founded in San Mateo by Rishi Bhalerao targeting predictive risk analytics for health insurers using clinical graph AI.
FUNDING
$20M raised from Khosla Ventures; signed data partnership with Blue Shield California for claims analytics.
PIVOT
HIPAA data access barriers capped model accuracy; IBM Watson Health signed 5 competing insurer contracts in same period.
ACQUISITION ATTEMPT
Acquired by Inovalon for approximately $22M; modest return on $20M raised over nine years.
Full Analysis
Free · no account needed
Documented cause
Lumiata raised $20M to build predictive analytics AI for enterprise health insurers and hospital systems, using clinical graph AI to identify high-risk patients. Despite backing from Khosla Ventures and contracts with Blue Shield California, the company faced HIPAA data sharing barriers that limited training dataset size. Competing platforms from IBM Watson Health and Google Cloud Health captured larger insurer relationships. In 2022, Lumiata was acquired by Inovalon for approximately $22M — a modest return on investment.
Lesson
“Healthcare AI startups must solve federated learning and data governance before writing a single sales contract.”